nach oben

European Archives of Oto-Rhino-Laryngology

Erschienen in:

07.04.2020 | Review Article

Definition of locally recurrent head and neck squamous cell carcinoma: a systematic review and proposal for the Odense–Birmingham definition

verfasst von: Max Rohde, Tine Rosenberg, Manan Pareek, Paul Nankivell, Neil Sharma, Hisham Mehanna, Christian Godballe

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 6/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The objectives of this study were (1) to systematically review current definitions of head and neck squamous cell carcinoma (HNSCC) recurrence and (2) to propose a definition of locally recurrent HNSCC.

Methods

A systematic literature review was performed according to the ‘Preferred Reporting Items for Systematic Reviews and Meta-Analyses’ statement in Medline, Embase, and Cochrane databases guided by the study question “What is the definition of local recurrence for patients with HN:SCC?”. All retrieved studies were reviewed and qualitatively analyzed.

Results

The systematic literature search resulted in 3467 publications after removal of duplicates. Forty studies were examined as full text, and a total of five were found suitable for inclusion. All five included studies dealt with definitions of second primary HNSCC and were based on the Warren and Gates Criteria; (1) each of the tumors are malignant, (2) each must be distinct, and (3) the probability of one being a metastasis of the other must be excluded. Each of the included studies added specific anatomical and/or temporal separation measures to the criteria of second primary HNSCC. We propose the definition of locally recurrent HNSCC to be: (1) Same anatomical subsite or adjacent subsite within 3 cm of the primary lesion, (2) time-interval no more than 3 years (from completed treatment of the primary lesion), and (3) same p16-status for oropharyngeal carcinomas.

Conclusions

No uniform definition of locally recurrent HNSCC currently exists. We propose the Odense–Birmingham definition based on the anatomical subsite combined with a specific measurable distance and a temporal separation of three years.

Ang KK, Trotti A, Brown BW, Garden AS, Foote RL, Morrison WH, Geara FB, Klotch DW, Goepfert H, Peters LJ (2001) Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 51(3):571–578. https://doi.org/10.1016/s0360-3016(01)01690-x CrossRefPubMed

Chang JH, Wu CC, Yuan KS, Wu ATH, Wu SY (2017) Locoregionally recurrent head and neck squamous cell carcinoma: incidence, survival, prognostic factors, and treatment outcomes. Oncotarget 8(33):55600–55612. https://doi.org/10.18632/oncotarget.16340 CrossRefPubMedPubMedCentral

Rohde M, Nielsen AL, Johansen J, Sorensen JA, Nguyen N, Diaz A, Nielsen MK, Asmussen JT, Christiansen JM, Gerke O, Thomassen A, Alavi A, Hoilund-Carlsen PF, Godballe C (2017) Head-to-head comparison of chest X-ray/head and neck MRI, chest CT/head and neck MRI, and (18)F-FDG PET/CT for detection of distant metastases and synchronous cancer in oral, pharyngeal, and laryngeal cancer. J Nucl Med 58(12):1919–1924. https://doi.org/10.2967/jnumed.117.189704 CrossRefPubMed

Bittorf B, Kessler H, Merkel S, Bruckl W, Wein A, Ballhausen WG, Hohenberger W, Gunther K (2001) Multiple primary malignancies: an epidemiological and pedigree analysis of 57 patients with at least three tumours. Eur J Surg Oncol 27(3):302–313. https://doi.org/10.1053/ejso.2001.1112 CrossRefPubMed

Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65(2):87–108. https://doi.org/10.3322/caac.21262 CrossRefPubMed

Cianfriglia F, Di Gregorio DA, Manieri A (1999) Multiple primary tumours in patients with oral squamous cell carcinoma. Oral Oncol 35(2):157–163CrossRef

Mehanna H, Kong A, Ahmed SK (2016) Recurrent head and neck cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol 130(S2):s181–s190. https://doi.org/10.1017/s002221511600061x CrossRefPubMedPubMedCentral

Rohde M, Nielsen AL, Johansen J, Sorensen JA, Diaz A, Pareek M, Asmussen JT, Gerke O, Thomassen A, Gyldenkerne N, Dossing H, Bjorndal K, Hoilund-Carlsen PF, Godballe C (2019) Upfront PET/CT affects management decisions in patients with recurrent head and neck squamous cell carcinoma. Oral Oncol 94:1–7. https://doi.org/10.1016/j.oraloncology.2019.04.025 CrossRefPubMed

Braakhuis BJ, Tabor MP, Leemans CR, van der Waal I, Snow GB, Brakenhoff RH (2002) Second primary tumors and field cancerization in oral and oropharyngeal cancer: molecular techniques provide new insights and definitions. Head Neck 24(2):198–206CrossRef

10.

Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535. https://doi.org/10.1136/bmj.b2535 CrossRefPubMedPubMedCentral

11.

Warren SGO (1932) Multiple primary malignant tumours: a survey of the literature and a statistical study. Am J Cancer 16:1358–1369

12.

Hong WK, Lippman SM, Itri LM, Karp DD, Lee JS, Byers RM, Schantz SP, Kramer AM, Lotan R, Peters LJ et al (1990) Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 323(12):795–801. https://doi.org/10.1056/nejm199009203231205 CrossRefPubMed

13.

Jovanovic A, van der Tol IG, Kostense PJ, Schulten EA, de Vries N, Snow GB, van der Waal I (1994) Second respiratory and upper digestive tract cancer following oral squamous cell carcinoma. Eur J Cancer Part B Oral Oncol 30(4):225–229CrossRef

14.

Adamo MDL, Ruhl J (2018) SEER program coding and staging manual. National Cancer Institute, Bethesda, p 20892

15.

Zukauskaite R, Hansen CR, Grau C, Samsoe E, Johansen J, Petersen JBB, Andersen E, Brink C, Overgaard J, Eriksen JG (2018) Local recurrences after curative IMRT for HNSCC: effect of different GTV to high-dose CTV margins. Radiother Oncol J Eur Soc Ther Radiol Oncol 126(1):48–55. https://doi.org/10.1016/j.radonc.2017.11.024 CrossRef

16.

Zbaren P, De Bree R, Takes RP, Rinaldo A, Ferlito A (2013) Which is the most reliable diagnostic modality for detecting locally residual or recurrent laryngeal squamous cell carcinoma after (chemo)radiotherapy? Eur Arch Otorhinolaryngol 270(11):2787–2791CrossRef

17.

Suenaga Y, Kitajima K, Ishihara T, Sasaki R, Otsuki N, Nibu K, Minamikawa T, Kiyota N, Sugimura K (2016) FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT. Eur Radiol 26(4):1018–1030. https://doi.org/10.1007/s00330-015-3902-1 CrossRefPubMed

18.

Leemans CR, Tiwari R, Nauta JJ, van der Waal I, Snow GB (1994) Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor. Cancer 73(1):187–190CrossRef

19.

Danaei G, Vander Hoorn S, Lopez AD, Murray CJ, Ezzati M (2005) Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet 366(9499):1784–1793. https://doi.org/10.1016/s0140-6736(05)67725-2 CrossRefPubMed

20.

Hashibe M, Brennan P, Chuang SC, Boccia S, Castellsague X, Chen C, Curado MP, Dal Maso L, Daudt AW, Fabianova E, Fernandez L, Wunsch-Filho V, Franceschi S, Hayes RB, Herrero R, Kelsey K, Koifman S, La Vecchia C, Lazarus P, Levi F, Lence JJ, Mates D, Matos E, Menezes A, McClean MD, Muscat J, Eluf-Neto J, Olshan AF, Purdue M, Rudnai P, Schwartz SM, Smith E, Sturgis EM, Szeszenia-Dabrowska N, Talamini R, Wei Q, Winn DM, Shangina O, Pilarska A, Zhang ZF, Ferro G, Berthiller J, Boffetta P (2009) Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomark Prev 18(2):541–550. https://doi.org/10.1158/1055-9965.epi-08-0347 CrossRef

21.

Carlander AF, Gronhoj Larsen C, Jensen DH, Garnaes E, Kiss K, Andersen L, Olsen CH, Franzmann M, Hogdall E, Kjaer SK, Norrild B, Specht L, Andersen E, van Overeem HT, Nielsen FC, von Buchwald C (2017) Continuing rise in oropharyngeal cancer in a high HPV prevalence area: a Danish population-based study from 2011 to 2014. Eur J Cancer (Oxford, England: 1990) 70:75–82. https://doi.org/10.1016/j.ejca.2016.10.015 CrossRef

22.

Garnaes E, Kiss K, Andersen L, Therkildsen MH, Franzmann MB, Filtenborg-Barnkob B, Hoegdall E, Lajer CB, Andersen E, Specht L, Joenson L, Frederiksen K, Friis-Hansen L, Nielsen FC, Kjaer SK, Norrild B, von Buchwald C (2015) Increasing incidence of base of tongue cancers from 2000 to 2010 due to HPV: the largest demographic study of 210 Danish patients. Br J Cancer 113(1):131–134. https://doi.org/10.1038/bjc.2015.198 CrossRefPubMedPubMedCentral

23.

Albergotti WG, Abberbock S, Mathews F, Ferris RL, Johnson JT, Duvvuri U, Kim S (2018) Oligometastatic status as predictor of survival in metastatic human papillomavirus-positive oropharyngeal carcinoma. Head Neck. https://doi.org/10.1002/hed.25171 CrossRefPubMed

24.

Anantharaman D, Billot A, Waterboer T, Gheit T, Abedi-Ardekani B, Lagiou P, Lagiou A, Ahrens W, Holcatova I, Merletti F, Kjaerheim K, Polesel J, Simonato L, Alemany L, Mena Cervigon M, Macfarlane TV, Znaor A, Thomson PJ, Robinson M, Canova C, Conway DI, Wright S, Healy CM, Toner ME, Pawlita M, Tommasino M, Brennan P (2018) Predictors of oropharyngeal cancer survival in Europe. Oral Oncol 81:89–94. https://doi.org/10.1016/j.oraloncology.2018.04.016 CrossRefPubMed

25.

Slaughter DP, Southwick HW, Smejkal W (1953) Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 6(5):963–968. https://doi.org/10.1002/1097-0142(195309)6:5%3c963:aid-cncr2820060515%3e3.0.co;2-q CrossRefPubMed

26.

Bedi GC, Westra WH, Gabrielson E, Koch W, Sidransky D (1996) Multiple head and neck tumors: evidence for a common clonal origin. Can Res 56(11):2484–2487

27.

Partridge M, Emilion G, Pateromichelakis S, Phillips E, Langdon J (1997) Field cancerisation of the oral cavity: comparison of the spectrum of molecular alterations in cases presenting with both dysplastic and malignant lesions. Oral Oncol 33(5):332–337CrossRef

28.

Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, Corio R, Lee D, Greenberg B, Koch W, Sidransky D (1996) Genetic progression model for head and neck cancer: implications for field cancerization. Can Res 56(11):2488–2492

Titel: Definition of locally recurrent head and neck squamous cell carcinoma: a systematic review and proposal for the Odense–Birmingham definition
verfasst von: Max Rohde
Tine Rosenberg
Manan Pareek
Paul Nankivell
Neil Sharma
Hisham Mehanna
Christian Godballe
Publikationsdatum: 07.04.2020
Verlag: Springer Berlin Heidelberg
Erschienen in: European Archives of Oto-Rhino-Laryngology / Ausgabe 6/2020
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI: https://doi.org/10.1007/s00405-020-05953-5

Neu im Fachgebiet HNO

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Eingreifen von Umstehenden rettet vor Erstickungstod

15.05.2024 Fremdkörperaspiration Nachrichten

Wer sich an einem Essensrest verschluckt und um Luft ringt, benötigt vor allem rasche Hilfe. Dass Umstehende nur in jedem zweiten Erstickungsnotfall bereit waren, diese zu leisten, ist das ernüchternde Ergebnis einer Beobachtungsstudie aus Japan. Doch es gibt auch eine gute Nachricht.

Real-World-Daten sprechen eher für Dupilumab als für Op.

14.05.2024 Rhinosinusitis Nachrichten

Zur Behandlung schwerer Formen der chronischen Rhinosinusitis mit Nasenpolypen (CRSwNP) stehen seit Kurzem verschiedene Behandlungsmethoden zur Verfügung, darunter Biologika, wie Dupilumab, und die endoskopische Sinuschirurgie (ESS). Beim Vergleich der beiden Therapieoptionen war Dupilumab leicht im Vorteil.

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Definition of locally recurrent head and neck squamous cell carcinoma: a systematic review and proposal for the Odense–Birmingham definition